Immune-mediated acute thrombocytopenia within 30 minutes of first obinutuzumab infusion
Blood Vessels, Thrombosis & Hemostasis
· Elsevier
Аннотация
Publication date: August 2026 Source: Blood Vessels, Thrombosis & Hemostasis, Volume 3, Issue 3 Author(s): Judy Al-Sayyad, Hugo R. Lara-Martinez
Читать у издателя →
Цитирование
Immune-mediated acute thrombocytopenia within 30 minutes of first obinutuzumab infusion. // Blood Vessels, Thrombosis & Hemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S2950327226000392?dgcid=rss_sd_all
Immune-mediated acute thrombocytopenia within 30 minutes of first obinutuzumab infusion. Blood Vessels, Thrombosis & Hemostasis. https://www.sciencedirect.com/science/article/pii/S2950327226000392?dgcid=rss_sd_all
“Immune-mediated acute thrombocytopenia within 30 minutes of first obinutuzumab infusion.” Blood Vessels, Thrombosis & Hemostasis.
@article{article88644,
title = {Immune-mediated acute thrombocytopenia within 30 minutes of first obinutuzumab infusion},
journal = {Blood Vessels, Thrombosis \& Hemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S2950327226000392?dgcid=rss_sd_all}
}